View in EDS HTML Full Text PDF Full Text

Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.

Saved in:
Bibliographic Details
Title: Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
Authors: Ackerson BK; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Bruxvoort KJ; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA., Qian L; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Sy LS; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Qiu S; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Tubert JE; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Lee GS; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Ku JH; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Florea A; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Luo Y; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Bathala R; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Stern J; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Choi SK; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Takhar HS; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Aragones M; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Marks MA; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA., Anderson EJ; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA., Zhou CK; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA., Sun T; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA., Talarico CA; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA.; Epidemiology, AstraZeneca, Gaithersburg, MD, USA., Tseng HF; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.
Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2335052. Date of Electronic Publication: 2024 Apr 04.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38575149
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ackerson+BK%22">Ackerson BK</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bruxvoort+KJ%22">Bruxvoort KJ</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.<br /><searchLink fieldCode="AU" term="%22Qian+L%22">Qian L</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sy+LS%22">Sy LS</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Qiu+S%22">Qiu S</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tubert+JE%22">Tubert JE</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lee+GS%22">Lee GS</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ku+JH%22">Ku JH</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Florea+A%22">Florea A</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Luo+Y%22">Luo Y</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bathala+R%22">Bathala R</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Stern+J%22">Stern J</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Choi+SK%22">Choi SK</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Takhar+HS%22">Takhar HS</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Aragones+M%22">Aragones M</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.<br /><searchLink fieldCode="AU" term="%22Marks+MA%22">Marks MA</searchLink>; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Anderson+EJ%22">Anderson EJ</searchLink>; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Zhou+CK%22">Zhou CK</searchLink>; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sun+T%22">Sun T</searchLink>; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Talarico+CA%22">Talarico CA</searchLink>; Infectious Disease, Epidemiology, Moderna Inc, Cambridge, MA, USA.; Epidemiology, AstraZeneca, Gaithersburg, MD, USA.<br /><searchLink fieldCode="AU" term="%22Tseng+HF%22">Tseng HF</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101572652%22">Human vaccines & immunotherapeutics</searchLink> [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2335052. <i>Date of Electronic Publication: </i>2024 Apr 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101572652 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2164-554X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221645515%22">21645515 </searchLink><i>NLM ISO Abbreviation: </i>Hum Vaccin Immunother <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38575149
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/21645515.2024.2335052
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2335052
    Titles:
      – TitleFull: Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ackerson BK
      – PersonEntity:
          Name:
            NameFull: Bruxvoort KJ
      – PersonEntity:
          Name:
            NameFull: Qian L
      – PersonEntity:
          Name:
            NameFull: Sy LS
      – PersonEntity:
          Name:
            NameFull: Qiu S
      – PersonEntity:
          Name:
            NameFull: Tubert JE
      – PersonEntity:
          Name:
            NameFull: Lee GS
      – PersonEntity:
          Name:
            NameFull: Ku JH
      – PersonEntity:
          Name:
            NameFull: Florea A
      – PersonEntity:
          Name:
            NameFull: Luo Y
      – PersonEntity:
          Name:
            NameFull: Bathala R
      – PersonEntity:
          Name:
            NameFull: Stern J
      – PersonEntity:
          Name:
            NameFull: Choi SK
      – PersonEntity:
          Name:
            NameFull: Takhar HS
      – PersonEntity:
          Name:
            NameFull: Aragones M
      – PersonEntity:
          Name:
            NameFull: Marks MA
      – PersonEntity:
          Name:
            NameFull: Anderson EJ
      – PersonEntity:
          Name:
            NameFull: Zhou CK
      – PersonEntity:
          Name:
            NameFull: Sun T
      – PersonEntity:
          Name:
            NameFull: Talarico CA
      – PersonEntity:
          Name:
            NameFull: Tseng HF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 12
              Text: 2024 Dec 31
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2164-554X
          Numbering:
            – Type: volume
              Value: 20
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Human vaccines & immunotherapeutics
              Type: main
ResultId 1